1. Males and females ≥ 18 years old. 
2. Clinical diagnosis of type 1 diabetes for at least one year. 
3. The subject will have been on insulin pump therapy for at least 3 months and currently using a fast actin insulin analog (Lispro, Aspart or Guilisine). 
4. Last (less than 3 months) HbA1c ≤ 10%. 
5. Currently using carbohydrate counting as the meal insulin dose strategy. 
